Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-05-24
2010-11-09
Gussow, Anne M. (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S130100, C424S138100, C530S387100, C530S387300, C530S387700
Reexamination Certificate
active
07829088
ABSTRACT:
The present invention is related to a pharmaceutical composition comprising humanized anti-4-1BB antibody (HBBK4) for treating cancer by inducing increase of CD11+CD8+ T cell and IFN-γ, and inhibiting proliferation of cancer cells, together with a pharmaceutically acceptable carrier and the use. Accordingly, it can be useful in the prevention or treatment of cancer without adverse response.
REFERENCES:
patent: 7585960 (2009-09-01), Hanke et al.
patent: 7592426 (2009-09-01), Ebel et al.
patent: 7658925 (2010-02-01), Groen et al.
Melero, Shuford, Newby, Aruffo, Ledbetter, Hellstrom, Mittler, and Chen. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nature Medicine, 1997. vol. 3, pp. 682-685.
Kocak, Chang, May, Abdessalam, Exten, Martin, Shen, Zheng, and Liu. AACR Meeting Abstract, Proceedings of the American Association of Cancer Research, 2005. vol. 46 (Suppl. 6) p. 1008. Abstract #4268.
Kocak, Lute, Chang, May, Exten, Zhang, Abdessalam, Lehman, Jarjoura, Zheng, and Liu. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Research, 2006. vol. 66 (14) pp. 7276-7284.
Nagorsen D. et al., Clin. Cancer Res. 9, pp. 4296-4303, 2003.
Yee C. et al., J. Exp. Med. 192, pp. 1637-1644, 2000.
Mondino A et al., J. Leukoc. Biol. 55, pp. 805-815, 1994.
Berzofsky, J.A. et al., J. Clin. Invest. 113, pp. 1515-1525, 2004.
Dunn CF et al., Immunity 21, pp. 137-148, 2004.
Ye Z et al., Nat. Med. 8, pp. 343-348, 2002.
Phan GQ et al., Proc. Natl. Acad. Sci. USA, 100, pp. 8372-8377, 2003.
Yu P et al., Nat. Immunol. 5, pp. 141-149, 2004.
Iwai Y et al., Int. Immunol. 17.pp. 133-144, 2005.
Arens R et al., J. Exp. Med. 199, pp. 1595-1605, 2004.
Shuford WW. et al, J. Exd. Med. 186, pp. 47-55, 1995.
Francia G et al., Cancer Res. 56, 3855-3858, 1996.
Seo SK et al., Nat. Med., 10, pp. 1088-1094, 2004.
Castelli C. et al., J. Cell Physiol., 182, pp. 323-331, 2000 (Abstract).
Li Q et al., J. Immunother., 25, pp. 304-313, 2002 (Abstract).
Gussow Anne M.
Hogan & Lovells US LLP
University of Ulsan Foundation for Industry Cooperation
LandOfFree
Composition comprising humanized antibody HBBK4 for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising humanized antibody HBBK4 for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising humanized antibody HBBK4 for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195409